The University of Chicago Header Logo

The dosing of ibrutinib and related Bruton's tyrosine kinase inhibitors: eliminating the use of brute force.

The dosing of ibrutinib and related Bruton's tyrosine kinase inhibitors: eliminating the use of brute force. Blood Adv. 2022 09 13; 6(17):5041-5044.

View in: PubMed